|
Growing great businesses Movac is an investment manager that backs exceptional people with world-beating ideas - ideas that have the potential for rapid and large-scale growth. The philosophy of the Movac Investor Group is to back high growth potential businesses that will provide the foundations for the next wave of prosperity for the New Zealand economy. Movac has a track record of investment success, most notably in Trademe.
Our typical investment ranges from $100k to $1m. We will look at larger deals under syndication with other investors.
Active ventures
|
Blog
OnYa Kiwi Entrepreneurs The quality that we're seeing in the opportunities being put in front of us is the best it's ever been. So good on you, Kiwi Entrepreneurs and their backers. Businesses that are up and running. Initial product development is done, market entry is mapped out and the core team is in place.
Mesynthes Obtains U.S. FDA 510(k) Clearance for Endoform Dermal Template™ WELLINGTON, NZ (February 2, 2010): Mesynthes, a privately held regenerative medicine company, today announced that the U. S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's Endoform Dermal TemplateTM.
|